Skip to main content

Table 2 Anti-inflammatory medications

From: Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data

Class

Agent

FDA pregnancy category

Adverse effects in human pregnancy

Summary risk assessment

Corticosteroids

Prednisone

C

Oral clefts increased risk (two- to three-fold). Intrauterine growth restriction (dose related)

Based on available data, teratogenic risk for corticosteroids is minimal

 

Cortisone

D

  
 

All others

C

  

NSAIDs

Celecoxib

C

Ibuprofen associated with increased risk (two- to three-fold) for gastroschisis. NSAIDs associated with increased risk for spontaneous abortion; possible increased risk for cardiac defects; premature closure of the ductus arteriosus with third trimester use

Significant risk for premature closure of the ductus arteriosus and other complications when exposure occurs in late pregnancy; minimal or undetermined risk for structural defects following first trimester exposure

 

Diclofenac

C

  
 

Ketorolac

C

  
 

Prixicam

C

  
 

All others

B

  
 

All NSAIDs in third trimester

D

  
  1. NSAIDs, non-steroidal anti-inflammatory drugs.